Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Luban

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Nature Medicine|October 10, 2019
Retraction Note: The hidden cost of genetic resistance to HIV-1Jeremy Luban
Current Biology : CB|August 30, 2008
HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integraseJeremy Luban
Journal of Virology|September 8, 2006
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infectionJeremy Luban
Nature Medicine|June 5, 2019
The hidden cost of genetic resistance to HIV-1Jeremy Luban
Elife|July 9, 2016
Closing the net on retrovirusesJeremy Luban
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2012
More than one way to TRIM a capsidJeremy Luban
Cell Host & Microbe|October 23, 2012
Innate immune sensing of HIV-1 by dendritic cellsJeremy Luban
Molecular Biology International|June 16, 2012
TRIM5 and the Regulation of HIV-1 InfectivityJeremy Luban
Retrovirology|June 22, 2005
TRIM5alpha selectively binds a restriction-sensitive retroviral capsidSarah Sebastian, Jeremy Luban
Current Infectious Disease Reports|February 28, 2007
The retroviral restriction factor TRIM5alphaSarah Sebastian, Jeremy Luban
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Nature Medicine|October 10, 2019
Retraction Note: The hidden cost of genetic resistance to HIV-1Jeremy Luban
Current Biology : CB|August 30, 2008
HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integraseJeremy Luban
Journal of Virology|September 8, 2006
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infectionJeremy Luban
Nature Medicine|June 5, 2019
The hidden cost of genetic resistance to HIV-1Jeremy Luban
Elife|July 9, 2016
Closing the net on retrovirusesJeremy Luban
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2012
More than one way to TRIM a capsidJeremy Luban
Cell Host & Microbe|October 23, 2012
Innate immune sensing of HIV-1 by dendritic cellsJeremy Luban
Molecular Biology International|June 16, 2012
TRIM5 and the Regulation of HIV-1 InfectivityJeremy Luban
Retrovirology|June 22, 2005
TRIM5alpha selectively binds a restriction-sensitive retroviral capsidSarah Sebastian, Jeremy Luban
Current Infectious Disease Reports|February 28, 2007
The retroviral restriction factor TRIM5alphaSarah Sebastian, Jeremy Luban
Pageof 16